Health Technology

Sysmex Corp.

In the news

Coronavirus-testing robot in Japan takes on key tasks, reducing lab strain Jun 4, 2020
Rapid-fire coronavirus kits aim to fill Japan's testing gap Apr 2, 2020
Robot injections? Makers look to bring automation to health care Apr 16, 2018
Otsuka invests in startup making iPS-derived blood platelets Dec 25, 2017
Tomorrow's game: Offshore production with robots Dec 7, 2017

Business Summary

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2022	JPY	USD
Revenue	363,780M	3,237.26M
Gross Profit	190,585M	1,696.00M
Operating income	69,566M	619.06M
Income before tax	67,907M	604.30M
Net income	44,092M	392.37M
EBITDA	96,997M	863.17M
Diluted EPS	210.49	1.87
Dividends Per Share	76	0.67
Total Assets	483,707M	3,985.22M
Total liabilities	134,898M	1,111.41M
Total equity	348,303M	2,869.64M
Operating cash flow	58,739M	522.71M
	Currency in JPY	Currency in USD

Historical Data

JPY | USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	281,935M	293,506M	301,980M	305,073M	363,780M
Gross Profit	158,949M	161,607M	159,807M	154,303M	190,585M
Operating income	59,947M	60,799M	54,501M	49,165M	69,566M
Income before tax	58,117M	57,955M	49,433M	49,334M	67,907M
Net income	39,221M	41,224M	34,882M	31,904M	44,092M
EBITDA	74,590M	76,641M	78,456M	74,581M	96,997M
Diluted EPS	187.84	197.28	166.92	152.47	210.49
Dividends Per Share	66	70	72	72	76
Total Assets	321,979M	346,775M	389,291M	424,895M	483,707M
Total liabilities	80,531M	81,588M	110,941M	118,955M	134,898M
Total equity	240,750M	264,449M	277,684M	305,318M	348,303M
Operating cash flow	52,240M	44,743M	53,182M	56,873M	58,739M

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	2,543.79M	2,646.70M	2,777.44M	2,876.48M	3,237.26M
Gross Profit	1,434.13M	1,457.30M	1,469.81M	1,454.90M	1,696.00M
Operating income	540.87M	548.25M	501.27M	463.56M	619.06M
Income before tax	524.36M	522.61M	454.65M	465.16M	604.30M
Net income	353.87M	371.74M	320.82M	300.81M	392.37M
EBITDA	672.99M	691.11M	721.59M	703.21M	863.17M
Diluted EPS	1.69	1.77	1.53	1.43	1.87
Dividends Per Share	0.59	0.63	0.66	0.67	0.67
Total Assets	3,027.54M	3,132.99M	3,606.04M	3,845.20M	3,985.22M
Total liabilities	757.22M	737.11M	1,027.65M	1,076.51M	1,111.41M
Total equity	2,263.75M	2,389.20M	2,572.21M	2,763.05M	2,869.64M
Operating cash flow	471.34M	403.47M	489.13M	536.24M	522.71M

Valuation Measures

Mar 2022
PER	42.31
ROA	9.70%
ROE	13.49%
Operating margin	19.12%
Profit margin	12.12%

Key executives

Chairman, Chief Executive Officer & President: Hisashi Ietsugu
Director, CTO & COO-LS Business Unit: Kaoru Asano
CFO, Director & Senior Managing Executive Officer: Yukio Nakajima
Manager-Informatics: Yasuhiro Takachi
Executive Officer: Keiji Fujimoto

Shareholders

Baillie Gifford & Co. (5.9%)
Kobe Yamabuki Foundation (5.7%)
Nakatani Foundation (5.6%)
Nakatani Kosan YK (4.9%)
IETSUGU KAZUKO (2.9%)
WADA TAEKO (2.9%)
BlackRock Fund Advisors (2.7%)
Nomura Asset Management Co., Ltd. (2.7%)
The Vanguard Group, Inc. (2.3%)
IETSUGU FAMILY (2.2%)

Contact Details

Website:http://www.sysmex.co.jp
Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
Phone: +81.78.265.0500

Related Companies

Sysmex Pilot Co. Ltd.
Sysmex Astrego AB
Oxford Gene Technology (Operations) Ltd.
Astrego Diagnostics AB
Sysmex Medical Electronics (Shanghai) Co., Ltd.
Sysmex Wuxi Co. Ltd.
Sysmex Inostics, Inc.
Sysmex Turkey Diagnostik Sistemleri Ltd. STI
Sysmex (Malaysia) Sdn.Bhd.
Sysmex Vietnam Co. Ltd.
Sysmex Taiwan Co. Ltd.
Sysmex Suisse AG
Sysmex Slovakia sro
Sysmex Shanghai Ltd.
Sysmex RUS LLC
Sysmex Polska Sp zoo
Sysmex Philippines, Inc.
Sysmex Hungaria Kft.
Sysmex Hong Kong Ltd.
Sysmex Espana SL
Sysmex do Brasil Industria e Comercio Ltda.
Sysmex CZ sro
Sysmex Canada, Inc.
Sysmex Austria GmbH
Sysmex Middle East FZ LLC
Sysmex South Africa (Pty) Ltd.
Sysmex Inostics GmbH
Sysmex Korea Co., Ltd.
Katakura Industries Co. Ltd. /Biological Research Center/
Sysmex RA Co. Ltd.

Competitors

Guardant Health, Inc.
General Biologicals Corp.
Haemonetics Corporation
Exact Sciences Corporation
Biocept, Inc.
SD Biosensor, Inc.
Epigenomics AG
Hangzhou Biotest Biotech Co., Ltd. Class A

Last Updated on 4 Oct, 2022